A hydroxyl radical-activated NIR-II hemicyanine photosensitizer for selective photodynamic cancer therapy
Chemical Communications · 2025
DOI: 10.1039/d5cc04760a ↗At a glance
Journal article in Chemical Communications, 2025. Written by Wenwen Cao and 3 co-authors. Institution: Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, College of Chemistry, Nankai University, Tia…. Major MEDLINE topics: Photosensitizing Agents, Photochemotherapy, Hydroxyl Radical, Carbocyanines. 35 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
A heavy-atom-free photosensitizer activated by hydroxyl radicals allows for the NIR-II fluorescence imaging and selective photodynamic treatment of cancer cells.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, College of Chemistry, Nankai University, Tianjin 300071, China. xionghu@nankai.edu.cn.
Funding
- National Natural Science Foundation of China
Cite
APA
Cao, W., Wu, F., Zheng, B., & Xiong, H. (2025). A hydroxyl radical-activated NIR-II hemicyanine photosensitizer for selective photodynamic cancer therapy. Chemical Communications. https://doi.org/10.1039/d5cc04760a
Vancouver
Cao W, Wu F, Zheng B, Xiong H. A hydroxyl radical-activated NIR-II hemicyanine photosensitizer for selective photodynamic cancer therapy. Chemical Communications. 2025. doi:10.1039/d5cc04760a
BibTeX
@article{Cao2025,
author = {Cao, Wenwen and Wu, Fapu and Zheng, Bingbing and Xiong, Hu},
title = {A hydroxyl radical-activated NIR-II hemicyanine photosensitizer for selective photodynamic cancer therapy},
journal = {Chemical Communications},
year = {2025},
doi = {10.1039/d5cc04760a}
}
EUVIMED